The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity
Open accessAbstract
The formation of extracellular amyloid plaques is a common patho-biochemical event underlying several debilitating human conditions, including Alzheimer’s disease (AD). Considerable evidence implies that AD damage arises primarily from small oligomeric amyloid forms of Aβ peptide, but the precise mechanism of pathogenicity remains to be established. Using a cell culture system that reproducibly leads to the formation of Alzheimer’s Aβ amyloid plaques, we show here that the formation of a single amyloid plaque represents a template-dependent process that critically involves the presence of endocytosis- or phagocytosis-competent cells. Internalized Aβ peptide becomes sorted to multivesicular bodies where fibrils grow out, thus penetrating the vesicular membrane. Upon plaque formation, cells undergo cell death and intracellular amyloid structures become released into the extracellular space. These data imply a mechanism where the pathogenic activity of Aβ is attributed, at least in part, to intracellular aggregates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although amyloid beta plaques are extracellular, mounting evidence suggests that aggregation also begins within neurons, where uptake and subsequent degradation within lysosomes has been dysregulated leading to intraneuronal accumulation leading to aggregation [14–20].”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [18]
Experimental — accuracy not yet measuredIn the citing paper
“Endosomal Aβ42 labeling by immuno-EM has since been confirmed by other groups [49, 95, 143].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,497
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
Atomic structures of amyloid cross-β spines reveal varied steric zippers
Sawaya, M. R., Sambashivan, S., Nelson, R. A., Ivanova, M. I., Sievers, S. A., Apostol, M. I., Thompson, M. J., Balbirnie, M., Wiltzius, J. J. W., McFarlane, H. T., et al. (2007) · Nature · doi:10.1038/nature05695 · Cited by 2,279
3D structure of Alzheimer's amyloid-β(1–42) fibrils
Lührs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., Schubert, D. A., & Riek, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506723102 · Cited by 2,001
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,462
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 302
Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline
Barnett, A. M., McNair, E. M., Dawkins, L., Zou, J., Nikolova, V. D., Moy, S. S., Sutherland, G. T., Stevens, J., Colie, M., Katemboh, K., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70486 · Cited by 12
Influence of amyloid beta on impulse spiking of isolated hippocampal neurons
Yavorsky, V. A., Rozumna, N. M., & Lukyanetz, E. A. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1132092 · Cited by 11
“in the initial stages precedes the appearance of amyloid deposits outside the cells (Gyure et al., 2001; Bossers et al., 2010; Friedrich et al., 2010).”
BackgroundInsulin amyloid structures and their influence on neural cells
Bystrenová, E., Bednáriková, Z., Barbalinardo, M., Valle, F., Gažová, Z., & Biscarini, F. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.10.054 · Cited by 11
Studies of the Process of Amyloid Formation by Aβ Peptide
Galzitskaya, O. V., Galushko, E. I., & Selivanova, O. M. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918140079 · Cited by 11
“can accumulate both inside and outside cells [94, 95].”
BackgroundTurégano-López, M., Santuy, A., DeFelipe, J., & Merchán-Pérez, Á. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz211 · Cited by 12
Gamal, N., Bakly, W. M. S. E., Saad, S. S. T., El-Waseef, D. A. E.-D. A., El‐Shal, A. S., Morsy, W. E., & Magdy, Y. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04136-5 · Cited by 10
“Once Aβ accumulates in MVBs, it penetrates the membrane, entering the cyto-plasm and causing cell death, extracellular Aβ deposition, and significant neuronal loss in the CA1 pyramidal cell layer, correlating with intraneuronal Aβ accumulation (Friedrich et al. 2010).”
Wang, J., Cheng, Q., Zhang, Y., Hong, C., Liu, J., Liu, X., & Chang, J. (2023) · Aging and Disease · doi:10.14336/ad.2023.0119 · Cited by 10
Autophagy: ‘Self-Eating’ Your Way to Longevity
Pattison, C. J., & Korolchuk, V. I. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_2 · Cited by 10
Identification of critical amino acid residues in the regulatory N-terminal domain of PMEL
Mitchell, S. M., Graham, M. M., Liu, X., & Leonhardt, R. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-87259-y · Cited by 10
Salazar, J., Poejo, J., Mata, A. M., Samhan-Arias, A. K., & Gutiérrez‐Merino, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042289 · Cited by 10
Lipoprotein Metabolism, Protein Aggregation, and Alzheimer’s Disease: A Literature Review
Grao‐Cruces, E., Claro, C., la Paz, S. M., & Nóbrega, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032944 · Cited by 15
“Therefore, protein degrading machinery is essential to degrade Aβ peptides and clear initial Aβ accumulation [34].”
BackgroundWesén, E. V., Lundmark, R., & Esbjörner, E. K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00053 · Cited by 9
Ikeda, K., Sugiura, Y., Nakao, H., & Nakano, M. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107248 · Cited by 9
LED-based interferometric reflectance imaging sensor for the detection of amyloid-β aggregation
Cheng, X. R., Daaboul, G. G., Ünlü, M. S., & Kerman, K. (2013) · The Analyst · doi:10.1039/c3an01307c · Cited by 9
Paikar, A., Debnath, M., Podder, D., Sasmal, S., & Haldar, D. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob00797c · Cited by 9
Reisz, J. A., Barrett, A. S., Nemkov, T. G., Hansen, K. C., & D’Alessandro, A. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1453362 · Cited by 11
“garnered attention only more recently [117].”
Aβ40 Aggregation under Changeable Conditions
Curto, J. S., Fernández, M. R., Cladera, J., Benseny‐Cases, N., & de Groot, N. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098408 · Cited by 9
The 3xTg-AD Mouse Model: A Comprehensive Tool for Understanding Alzheimer’s Disease
Pattanayak, A., & Firdous, S. M. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01655-w · Cited by 13
“Among these, Aβ42 stands out as the most hydrophobic and highly prone to forming amyloid plaques, making it a key component of the pathogenic plaques seen in AD (Friedrich et al. 2010).”
Molecular mechanisms of aging in the pathogenesis of Alzheimer’s disease
Kakkar, A., Singh, H., Singh, B. K., Chauhan, K., Chopra, S., Chopra, H., & Mishra, A. K. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00243-y · Cited by 9
“The mechanism of Aβ has been the subject of much public debate, such as the Aβ plaque formation [171].”
Olson, M. N., Dawes, P., Murray, L. F., Barton, N., Sundstrom, J., Orszulak, A. R., Chigas, S. M., Tran, K., Aylward, A. J., Caliandro, M. F., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00066-y · Cited by 7
Novel molecular mechanisms in Alzheimer’s disease: The potential role of DEK in disease pathogenesis
Greene, A. N., Solomon, M. B., & Vinnedge, L. M. P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1018180 · Cited by 8
“However, extracellular Aβ can become toxic when it interferes with synaptic receptors (Westmark, 2013), is internalized and aggregates to trigger cell death (Friedrich et al., 2010), and when plaque formation and deposition occurs, as is observed in AD (Hardy and Allsop, 1991; Seeman and Seeman, 2011).”
BackgroundZoltowska, K. M., Das, U., Lismont, S., Enzlein, T., Maesako, M., Houser, M. C., Franco, M. L., Özcan, B., Moreira, D. G., Karachentsev, D., et al. (2023) · eLife · doi:10.7554/elife.90690 · Cited by 14
Kaneko, N., Yoshimori, T., Yamamoto, R., Capon, D. J., Shimada, T., Sato, T., & Tanaka, K. (2013) · Analytical Chemistry · doi:10.1021/ac303344h · Cited by 8
The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease
Bhaskar, K., & Lamb, B. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_5 · Cited by 8
Mechanism of Cellular Formation and In Vivo Seeding Effects of Hexameric β-Amyloid Assemblies
Vrancx, C., Vadukul, D. M., Suelves, N., Contino, S., D’Auria, L., Perrin, F., Pesch, V. V., Hanseeuw, B. J., Quinton, L., & Kienlen‐Campard, P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02567-8 · Cited by 9
Intracellular tracing of amyloid vaccines through direct fluorescent labelling
Mold, M. J., Kumar, M., Mirza, A., Shardlow, E., & Exley, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-20845-9 · Cited by 7
Blinov, N., Wishart, D. S., & Kovalenko, A. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b00480 · Cited by 7
Shardlow, E., Khan, B., & Exley, C. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126766 · Cited by 7
Banerjee, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00019-0 · Cited by 7
Zhao, Q., Ma, L., Chen, S., Huang, L., She, G., Sun, Y., Shi, W., & Mu, L. (2024) · Talanta · doi:10.1016/j.talanta.2024.125716 · Cited by 6
MURAKOSHI, Y., Takahashi, T., & Mihara, H. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201202762 · Cited by 6
Sharma, A., Yadav, A., Cwiklinski, K., Quaye, E., Aalinkeel, R., Mahajan, S. D., Schwartz, S. A., & Sharma, R. K. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101314 · Cited by 6
Using Optogenetics to Model Cellular Effects of Alzheimer’s Disease
Tiwari, P., & Tolwinski, N. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054300 · Cited by 7
Farina, M. P., Saenz, J. L., & Crimmins, E. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285220 · Cited by 5
Saleh, O. M., Albakri, K. A., Altiti, A., Abutair, I., Shalan, S. S., Mohd, O. B., Negida, A., Mushtaq, G., & Kamal, M. A. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230519113201 · Cited by 5
A novel approach for addressing Alzheimer's disease: The chemo‐optical synergism
Sommer, A. P. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23044 · Cited by 5
“According to recent research, extracellular Ab can enter brain cells, resulting in neurotoxicity (Friedrich et al., 2010).”
BackgroundWan, Z., & Ma, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0303486 · Cited by 4
p75NTR is mainly responsible for Aβ toxicity but not for its internalization: a primary study
Yu, H., Yang, M., Wang, Y., Xiao, R., & Zhou, X. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0892-x · Cited by 4
“However, several previous researchers have claimed that the majority of internalized Ab did not co-localize with EEA1 (a marker of early endosomes) [27] and Lamp2 (a marker of lysosomes) [7].”
BackgroundPrabhu, M. P. T., Chrungoo, S., & Sarkar, N. (2023) · The Protein Journal · doi:10.1007/s10930-023-10157-x · Cited by 4
“These fibrils can excite oxidation of cell membrane, interfere with the mitochondrial functioning, also can alter ion homeostasis, and promote apoptosis [1].”
BackgroundSalazar, J., Samhan-Arias, A. K., & Gutiérrez‐Merino, C. (2023) · Molecules · doi:10.3390/molecules28207138 · Cited by 4
“After the uptake of extracellular A β (1–42) into neurons, the intracellular aggregates elicit neuronal damage and neurotoxicity [8,9,26,27].”
BackgroundBallesteros‐Álvarez, J., Nguyen, W., Sivapatham, R., Rane, A., & Andersen, J. K. (2022) · Research Square · doi:10.21203/rs.3.rs-2046848/v1 · Cited by 4
Zoltowska, K. M., Das, U., Lismont, S., Enzlein, T., Maesako, M., Houser, M. C., Franco, M. L., Özcan, B., Moreira, D. G., Karachentsev, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.02.551596 · Cited by 4
Armstrong, C., Luo, D., Gretzinger, A., Pandey, D., Lipchik, A. M., Todi, S. V., & Dutta, A. K. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00220 · Cited by 3
The Role of Long Non-Coding RNA in Anxiety Disorders: A Literature Review
López-Rocha, L. D., Ruíz-Hernández, A., Martínez-Coronilla, G., Leija-Montoya, A. G., Peña-Peña, M., Sánchez‐Muñoz, F., Campoy, U. R., & González-Ramírez, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115042 · Cited by 4
“…where the upregulation of a lncRNA that has been implicated in the regulation of beta-secretase 1 (BACE1), an enzyme involved in the formation of amyloid plaques, a common pathobiochemical event underlying several debilitating human diseases, including Alzheimer’s, has been found [115,116].”
Jain, S., Swain, S., Das, L., Swain, S., Giri, L., Kondapi, A. K., & Unni, H. N. (2020) · Bioengineering · doi:10.3390/bioengineering7040162 · Cited by 3
“Amyloid-β protein outside the neuronal space is yet another hallmark of AD progression [29].”
BackgroundChang, P., Li, X., Lin, J., Li, C., & Li, S. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123410 · Cited by 3
Capillary Flow-Based One-Minute Quantification of Amyloid Proteolysis
Lee, T., Cheong, D. Y., Lee, K. H., You, J. H., Park, J., & Lee, G. (2024) · Biosensors · doi:10.3390/bios14080400 · Cited by 3
Garth, F. (2011) · InTech eBooks · doi:10.5772/27973 · Cited by 3
“and/or trafficking vesicles associated with unconventional secretion (35, 78, 140, 142),”
BackgroundGarvey, M., Baumann, M., Wulff, M., Kumar, S. T., Markx, D., Morgado, I. M., Knüpfer, U., Horn, U., Mawrin, C., Fändrich, M., et al. (2016) · Amyloid · doi:10.3109/13506129.2016.1146989 · Cited by 3
“In these measurements we compared fibrils formed in CSF solutions from two different donors, P-fibrils and Ab(1–40) fibrils extracted from a previously described cell culture model of Ab amyloid plaque formation [26], termed CC-fibrils.”
BackgroundMethodSelf-citationSynapse-associated neuropathological markers in Alzheimer's disease
Barrantes, F. J. (2026) · Brain · doi:10.1093/brain/awag117 · Cited by 2
Lee, T., Seo, Y., Hwang, W., Choi, S., Bae, M., Kang, D., Roh, S., Lee, H., Kim, S., & Lee, G. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c02272 · Cited by 2
Farhadieh, M., Mozafar, M., Sanaaee, S., Sodeifi, P., Kousha, K., Zare, Y., Zare, S., Rad, N. M., Goharrizi, F. J., Allahverdloo, M., et al. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105576 · Cited by 2
“Higher levels of P-tau and lower A β levels is commonly reported in AD (Friedrich et al., 2010, Hansson et al., 2017), as A β causes amyloid plaques in the brain, whereas P-tau causes neurofibrillary tangles.”
Fight Aβ Aggregation with Molecular Aggregates
Wang, C. H., Zhang, D., Hu, M., & Wang, X. (2025) · Macromolecular Chemistry and Physics · doi:10.1002/macp.202400531 · Cited by 2
Yoon, J. H., Maeng, J., Kim, Y., Koo, G., Shim, J. S., Im, S., Jung, S., Shin, J., Jang, G. Y., Kim, S.-S., et al. (2025) · Antioxidants · doi:10.3390/antiox14101250 · Cited by 2
“Additionally, cathepsin-D leaks out from lysosomes and damages intracellular organelles [32,33],.”
Vingtdeux, V., Buée, L., & Sergeant, N. (2011) · InTech eBooks · doi:10.5772/20567 · Cited by 1
“to amyloid plaque formation (Friedrich et al., 2010).”
Free Cholesterol — A Double-Edge Sword in Alzheimer Disease
Fernández-Checa, J. C. (2015) · InTech eBooks · doi:10.5772/59935 · Cited by 3
Gao, Q., Fang, Y., Zhang, S., Li, H., Yung, K. K. L., & Lai, K. W. C. (2018) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2018.2800723 · Cited by 3
“After reviewing various Aβ-related studies and product information [31], [32], 50 μM pre-incubated Aβ1-40 oligomers were selected to treat neuronal cells for 24 h at 37 °C in an incubator to maintain cell conditions needed for our observations.”
MethodSun, M., Zhao, Y., Han, M., Zhang, B., Zhang, X., Zhang, Q., Lim, N. K.-H., Wang, W.-A., & Huang, F.-D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170907 · Cited by 2
Chude-Okonkwo, U. A. K., Malekian, R., & Maharaj, B. T. (2019) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-030-11003-1_7 · Cited by 2
Gutiérrez‐Merino, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813846 · Cited by 4
“The mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity [9].”
Baral, R., van Deventer, R., & Lyubchenko, Y. L. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70380 · Cited by 1
“Evidence from the literature links AD pathogenesis with an increased concentration of cholesterol (Friedrich et al. 2010; Habchi et al. 2018; Wingo et al. 2019).”
Pierzynowska, K., Gaffke, L., Cyske, Z., Jerzemowska, G., Węgrzyn, G., & Podlacha, M. (2026) · Nutritional Neuroscience · doi:10.1080/1028415x.2026.2634117 · Cited by 1
Melatonin: A versatile neuroprotective molecule in neurodegenerative diseases: A narrative review
Jazi, A. A., Yousefi, S., Reiter, R. J., Mojaveraghili, S. B., Amirkhanlou, S., Yekani, M., Farzanegan, S., Mir, S. M., & Memar, M. Y. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103884 · Cited by 1
Sutariya, N. M., Prasad, S., Athavale, D., Bhavsar, R. D., & Roy, I. (2013) · BioFactors · doi:10.1002/biof.1121 · Cited by 1
Understanding Alzheimer’s disease at the chemistry level
Xu, Y., Huang, Z., & Mu, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16140-7.00008-0 · Cited by 1
Merino‐Serrais, P., Plaza‐Alonso, S., Tapia‐González, S., León‐Espinosa, G., & DeFelipe, J. (2025) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2025.1571514 · Cited by 2
Catabolism and Anabolism of Amyloid-β
Hashimoto, S., Nilsson, P., & Saido, T. C. (2015) · Springer eBooks · doi:10.1007/978-4-431-55763-0_19 · Cited by 2
Fantini, J., & Yahi, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800111-0.00011-4 · Cited by 1
Heparan Sulfate in the Amyloidosis and Inflammation of Alzheimer’s Disease
O′Callaghan, P. W. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Ahmad, W. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/228437 · Cited by 1
Tachibana, T., & Kuwabara, T. (2019) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2019.01.006 · Cited by 1
Gibson, O. G. (2013) · Aquila Digital Community (University of Southern Mississippi)
Regulation of expression and cellular release of acetylcholinesterase
Hicks, D. A. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Antibody Based Therapeutics for Alzheimer's Disease
Boddapati, S. P. (2011)
MOLECULAR AND CELLULAR STUDIES OF TRANSTHYRETIN AND RELATED AMYLOID PATHOGENESIS
Fong, V. H. (2011) · Summit (Simon Fraser University)
Ultrastructural Arguments for the Extracellular Location of Amyloid Deposits
Mandache, E., Penescu, M. N., & Davila, C. (2015) · Medicina Moderna - Modern Medicine
Aβ Fibril Polymorphism and Alzheimer’s Disease
Bereza, M., & Fändrich, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00017-1
Self-citationKurudenkandy, F. R. (2016) · Figshare
Metabolic study of Alzheimer’s disease using mutant C. elegans
Ahmad, W. (2017) · The University of Queensland · doi:10.14264/uql.2017.500
“This is presumed because an early cognitive decline appears before the deposition of oligomers to form plaques in patients with AD [14-20].”
BackgroundMarkx, D., Loos, C., Claus, S., Haupt, C., Mawrin, C., & Fändrich, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.137
Self-citationMyco-Nanoparticles: A Novel Approach for Inhibiting Amyloid-β Fibrillation
Saran, A., Boddula, R., Dubey, P., Pothu, R., & Gautam, S. (2018) · Nanotechnology in the life sciences · doi:10.1007/978-3-319-99570-0_3
Adiutori, R., Puentes, F., Bremang, M., Lombardi, V., Zubiri, I., Leoni, E., Aarum, J., Sheer, D., McArthur, S., Pike, I., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.30.070979
“Investigations into biomarkers for Amyotrophic Lateral Sclerosis (ALS), a fatal neurodegenerative disorder, and for Alzheimer’s disease, have focused on neurofilaments (Nf), tau and beta amyloid proteins based on their propensity to package into complex protein assemblies, including fibrillary formations and aggregate…”
BackgroundWater: a major requisite for the protein fibrillation as revealed by THz spectroscopy measurements
Pyne, P., Samanta, N., Gohil, H., Prabhu, S. S., & Mitra, R. K. (2021) · International Conference on Infrared, Millimeter, and Terahertz Waves (IRMMW-THz) · doi:10.1109/irmmw-thz50926.2021.9567303
Upregulation of Trem2 expression occurs exclusively on microglial contact with plaquesPreprint
Wood, J. I., Wong, E., Joghee, R., Balbaa, A., Vitanova, K. S., VanSchoiack, A., Phelan, S.-L. J., Launchbury, F., Desai, S., Tripathi, T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.26.477873
“An alternative explanation could be that the Trem2 R47H mutation results in constant seeding of plaques either de novo (Friedrich et al., 2010) or by small plaques breaking off from the larger plaques.”
BackgroundBallesteros‐Álvarez, J., Nguyen, W., Sivapatham, R., Rane, A., & Andersen, J. K. (2022) · Research Square · doi:10.21203/rs.3.rs-2046848/v2
Ablation of cell-specific cholesterol synthesis affects cerebral β-amyloidosis
Spieth, L. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9780
“Further conversion from fibrils to amyloid plaques is not well understood but some studies described intracellular Aβ accumulations in various cells after repetitive synthetic Aβ induction (Friedrich et al., 2010; Gellermann et al., 2006).”
BackgroundHanotte, J. L. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/161150
Application of Cadherin cRNA Probes in Brains of Alzheimer’s Disease Mouse Model
Zhou, H., Du, S. J., Gendi, F., Li, H., Fu, J., & Chang, C. (2024) · Molecular Biology · doi:10.1134/s0026893324700134
Zoltowska, K. M., Das, U., Lismont, S., Enzlein, T., Maesako, M., Houser, M. C., Franco, M. L., Özcan, B., Moreira, D. G., Karachentsev, D., et al. (2024) · eLife · doi:10.7554/elife.90690.2
Walker, W. P., Ratz-Mitchem, M. L., Wagner, K., & Gunn, T. M. (2025) · Biomolecules · doi:10.3390/biom15060786
Baral, R., van Deventer, R., & Lyubchenko, Y. L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.20.671368
Jana, A. K., Khatua, P., & Bandyopadhyay, S. (2025) · Journal of Chemical Sciences · doi:10.1007/s12039-025-02426-2
“9 10–12 Both secretases exhibit variable site specificity for APP, producing A b peptides of different lengths, particularly at the C-terminus.”
Joshi, P., Riffel, F., Kumar, S., Villacampa, N., Theil, S., Parhizkar, S., Haass, C., Colonna, M., Heneka, M. T., Arzberger, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829558
Röhr, D., Boon, B. D. C., Schuler, M., Kremer, K., Hoozemans, J. J. M., Bouwman, F. H., El‐Mashtoly, S. F., Nabers, A., Großerueschkamp, F., Rozemüller, A. J. M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13467957
Joshi, P., Riffel, F., Kumar, S., Villacampa, N., Theil, S., Parhizkar, S., Haass, C., Colonna, M., Heneka, M. T., Arzberger, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829555
Montero‐Calle, A., Coronel, R., Manosalva, J., Megı́as, D., Rı́os, V. D. L., Rábano, A., Peláez‐García, A., Martínez‐Useros, J., Fernández‐Aceñero, M. J., Liste, I., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71090
Konstantoulea, K., Ramakers, M., Borrie, S. C., T’Syen, D., Moechars, D., Śliwińska, M. A., Pradhan, B., Albertini, G., Baligács, N., Tsaka, G., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2516774123
Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c
Binding and internalization of exogenous protein assemblies by mammalian cells
Ruiz-Arlandis, G. (2015) · theses.fr (ABES) · doi:10.70675/437e0532ze4e1z4966z80e5z340b6fd3c49d
Castelot, R. (2024) · theses.fr (ABES) · doi:10.70675/c2a7ce1ez8caaz4593zbb3azae8add8055b5
Metadata
- Authors
- Friedrich, R. P., Tepper, K., Rönicke, R., Soom, M., Westermann, M., Reymann, K., Kaether, C., & Fändrich, M.
- Affiliations
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
- Leibniz Institute for Neurobiology (DE)
- Friedrich Schiller University Jena (DE)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-01-19
- Volume
- 107
- Issue
- 5
- Pages
- 1942-1947
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2836607
- OpenAlex
- W2036172794
- Cited by
- 303
- References
- 63
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 20 · 2023: 20 · 2022: 13 · 2021: 21 · 2020: 23 · 2019: 11 · 2018: 30 · 2017: 28 · 2016: 15 · 2015: 18 · 2014: 8 · 2013: 24 · 2012: 13
- FWCI
- 15.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid plaque formation, amyloid-beta, Alzheimer's disease, multivesicular bodies, endocytosis, phagocytosis, cell death, amyloid-beta oligomers
- MeSH terms
- Alzheimer Disease, Animals, Cell Line, Chlorocebus aethiops, Freeze Fracturing, Humans, Intracellular Fluid, Microscopy, Electron, Scanning, Peptide Fragments, Amyloid beta-Peptides, Microscopy, Video, COS Cells, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
